CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 24 enrolled
Drug / intervention
Meniscal Allograftbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01673347
NCT01673347Phase 3Completed
CompareCT.gov

Allograft Knee Meniscal Transplantation in the Treatment of Osteoarthritis of the Metatarsophalangeal (MTP) Joint of the Great Toe

Paul Fortin, MD·interventional·Posted Aug 28, 2012·Updated May 23, 2017

In Brief

A Phase 3 clinical trial evaluating Meniscal Allograft for Osteoarthritis. Completed, enrolled 24 participants across 1 site.

Detailed Summary

Using the concept of an implant acting as a spacer and stabilizer, the proposed study will evaluate the use of allograft knee meniscus in the treatment of MTP joint osteoarthritis of the great toe.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesUnited States
CollaboratorsMusculoskeletal Transplant Foundation

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 28, 2012
Enrollment StartSep 1, 2010
Primary CompletionMay 1, 2014
Study CompletionMar 10, 2017
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 13.8 years ago

Interventions

Meniscal Allograftbiological

Meniscal allograft